CN105412623A - 治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物 - Google Patents
治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物 Download PDFInfo
- Publication number
- CN105412623A CN105412623A CN201510957777.1A CN201510957777A CN105412623A CN 105412623 A CN105412623 A CN 105412623A CN 201510957777 A CN201510957777 A CN 201510957777A CN 105412623 A CN105412623 A CN 105412623A
- Authority
- CN
- China
- Prior art keywords
- medicine
- weight portion
- diabetes
- prostatitis
- nephralgia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 83
- 208000004930 Fatty Liver Diseases 0.000 title claims abstract description 28
- 206010019708 Hepatic steatosis Diseases 0.000 title claims abstract description 28
- 208000010706 fatty liver disease Diseases 0.000 title claims abstract description 28
- 231100000240 steatosis hepatitis Toxicity 0.000 title claims abstract description 28
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 27
- 201000007094 prostatitis Diseases 0.000 title claims abstract description 27
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 19
- 201000008383 nephritis Diseases 0.000 title claims abstract description 18
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 13
- 241000222336 Ganoderma Species 0.000 claims abstract description 12
- 241001030098 Lethariella cladonioides Species 0.000 claims abstract description 8
- 241000937789 Rhodobryum giganteum Species 0.000 claims abstract description 8
- 238000005554 pickling Methods 0.000 claims abstract description 6
- 241001312214 Epipremnum aureum Species 0.000 claims abstract 3
- 238000011282 treatment Methods 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000012266 salt solution Substances 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 15
- 235000021110 pickles Nutrition 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 12
- 102000002322 Egg Proteins Human genes 0.000 claims description 10
- 108010000912 Egg Proteins Proteins 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 10
- 241000272522 Anas Species 0.000 claims description 8
- 210000004681 ovum Anatomy 0.000 claims description 8
- 241000723353 Chrysanthemum Species 0.000 claims description 7
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 7
- 241001480612 Ganoderma resinaceum Species 0.000 claims description 7
- 241000169546 Lycium ruthenicum Species 0.000 claims description 7
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 7
- 239000010931 gold Substances 0.000 claims description 7
- 229910052737 gold Inorganic materials 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 55
- 235000013601 eggs Nutrition 0.000 abstract description 49
- 210000004185 liver Anatomy 0.000 abstract description 27
- 150000003839 salts Chemical class 0.000 abstract description 22
- 210000003734 kidney Anatomy 0.000 abstract description 20
- 208000006454 hepatitis Diseases 0.000 abstract description 5
- 231100000283 hepatitis Toxicity 0.000 abstract description 3
- 230000002633 protecting effect Effects 0.000 abstract description 2
- 244000144977 poultry Species 0.000 abstract 2
- 241000272525 Anas platyrhynchos Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 241000305492 Gastrodia Species 0.000 abstract 1
- 241000608170 Gymnadenia conopsea Species 0.000 abstract 1
- 240000001910 Momordica cochinchinensis Species 0.000 abstract 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 abstract 1
- 244000042430 Rhodiola rosea Species 0.000 abstract 1
- 235000003713 Rhodiola rosea Nutrition 0.000 abstract 1
- 240000005319 Sedum acre Species 0.000 abstract 1
- 241001646984 Thamnolia Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 29
- 239000008280 blood Substances 0.000 description 29
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 201000010099 disease Diseases 0.000 description 13
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 206010028980 Neoplasm Diseases 0.000 description 11
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 239000012267 brine Substances 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 210000002307 prostate Anatomy 0.000 description 10
- 238000011160 research Methods 0.000 description 10
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 230000003203 everyday effect Effects 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 238000002604 ultrasonography Methods 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 6
- 230000001093 anti-cancer Effects 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 210000000496 pancreas Anatomy 0.000 description 6
- 150000003904 phospholipids Chemical class 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 210000000626 ureter Anatomy 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 244000252337 Epipremnum pinnatum Species 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 206010016256 fatigue Diseases 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 206010025135 lupus erythematosus Diseases 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 206010010741 Conjunctivitis Diseases 0.000 description 3
- 108010023302 HDL Cholesterol Proteins 0.000 description 3
- 208000007443 Neurasthenia Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- 241000256844 Apis mellifera Species 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- 208000010445 Chilblains Diseases 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 206010009900 Colitis ulcerative Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011732 Cyst Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 208000032139 Halitosis Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 241000131808 Scolopendra Species 0.000 description 2
- 241000239226 Scorpiones Species 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 201000006704 Ulcerative Colitis Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 208000031513 cyst Diseases 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 210000003278 egg shell Anatomy 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 230000000055 hyoplipidemic effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 201000001371 inclusion conjunctivitis Diseases 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000003228 intrahepatic bile duct Anatomy 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 229930013686 lignan Natural products 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- 150000005692 lignans Chemical class 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 210000000440 neutrophil Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 210000005070 sphincter Anatomy 0.000 description 2
- 230000007103 stamina Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000021147 sweet food Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 206010044325 trachoma Diseases 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- YEBDWAHEIMUJQT-ZLCLUPBPSA-N (5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O.CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YEBDWAHEIMUJQT-ZLCLUPBPSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- HBOQXIRUPVQLKX-UHFFFAOYSA-N 2,3-di(octadeca-9,12-dienoyloxy)propyl octadeca-9,12-dienoate Chemical compound CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC HBOQXIRUPVQLKX-UHFFFAOYSA-N 0.000 description 1
- 208000000197 Acute Cholecystitis Diseases 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008614 Cholecystitis acute Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010011715 Cyclitis Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 208000008574 Intracranial Hemorrhages Diseases 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037597 Pyelonephritis acute Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 241001646982 Thamnolia vermicularis Species 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 108010062497 VLDL Lipoproteins Proteins 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047791 Vulvovaginal dryness Diseases 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 201000005661 acute cystitis Diseases 0.000 description 1
- 201000001555 acute pyelonephritis Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000015496 breakfast cereal Nutrition 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 229940125753 fibrate Drugs 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000005934 immune activation Effects 0.000 description 1
- 230000006450 immune cell response Effects 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 210000002864 mononuclear phagocyte Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 208000002003 vulvitis Diseases 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000009530 yishen Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/09—Lichens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/10—Bryophyta (mosses)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物,该药物是将包括桦树茸、灰蔸巴、红景天、阴阳子、何首乌、绿萝花、灵芝、金丝红雪茶、天麻子、茴心草、白雪茶、手掌参等18种中药成分与食盐共同腌制禽蛋(鸡蛋或鸭蛋),即获得药物;或者将腌制后的禽蛋与药汁混合,得到药物。该药物能有效治疗前列腺炎、糖尿病、肾痛肾炎,还对脂肪肝及肝炎患者的治疗具有良好效果,保肝护肝,护肾保肾。
Description
技术领域
本发明涉及一种治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物
背景技术
脂肪肝属于可逆性疾病,早期诊断并及时治疗可恢复正常,但如不及时治疗,会进一步发展成为肝炎、肝硬化、肝癌等。目前临床上用于治疗脂肪肝的药物主要分为降血脂药、护肝降脂药和中医中药三大类,降血脂药包括苯氧芳酸类、三经甲基戊二酞‐辅酶A还原酶抑制剂等,由于脂肪肝常伴有肝脏脂质代谢障碍,降血脂药物驱使血脂更集中于肝脏进行代谢,进而损害肝功能。
申请号为201110372070.6的说明书中公开了一种治疗前列腺炎的中药组合物,它是由以下重量份数的原料制成:泽泻174份、车前子35份、败酱草348份、金银花174份、牡丹皮174份、白花蛇舌草348份、赤芍174份、仙鹤草174份、黄连174份、黄柏174份。这种治疗前列腺炎的中药组合物治疗前列腺炎速度慢。
糖尿病以口渴多饮、纳食增加、尿量增多、体质消瘦、体重减轻为主要症状,俗称“三多一少”,在临床中,也有无“三多一少”症状的。由于血中游离胰岛素和结合胰岛素增高,拮抗胰岛素物质增加,胰岛素合成性质的改变,造成血糖、尿糖的增高,中医称为消渴病,分为:上、中、下三消。此病严重影响患者的生活质量。目前现有的西医治疗多以长期服用降糖药、注射胰岛素为主要治疗方法,但药物副作用大,远期疗效不佳,治疗费用较高,给病人及家属带来很大的痛苦和经济负担。
发明内容
本发明的目的在于针对现有技术的不足,提供一种治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物。
本发明的目的是通过以下技术方案实现的:一种治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物,所述药物通过以下方法制备得到:
将10000~18000g的水加热至100摄氏度,加入1500~3000g食盐,得到食盐溶液;将食盐溶液自然冷却到20~30℃后,加入药物,泡浸两至三天,得到药物浸出液;将180个的禽蛋放入药物浸出液中腌制20~40天,腌制后的禽蛋即为治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物;所述禽蛋为鸡蛋或鸭蛋;
所述药物由以下成分组成:桦树茸100~200g、灰蔸巴200~300g、红景天100~200g、阴阳子100~200g、何首乌100~200g、绿萝花50~100g、灵芝100~200g、金丝红雪茶50~100g、天麻子100~200g、茴心草100~200g、白雪茶100~200g、手掌参50~100g、昆仑雪菊50~100g、龙胆花100~200g、杜仲50~100g、亚麻籽100~200g、野生无柄灵芝50~100g、野生黑枸杞50~100g。
一种治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物,所述药物通过以下步骤制备得到:
(1)将15000g水加热至100℃,加入500~900g食盐,得到食盐溶液;将食盐溶液自然冷却到20~30℃后,加入1500g药物,泡浸2~3个小时;然后在100℃下加热20‐30分钟,得到药汁;
(2)将7000~10000g水加热至100℃,加入2000~3000g食盐,得到食盐溶液;将食盐溶液自然冷却到20~30℃后,加入1000g药物,泡浸两至三天,得到药物浸出液;再将4000~6500g的禽蛋放入药物中腌制20~40天;所述禽蛋为鸡蛋或鸭蛋;
(3)将步骤2腌制后的禽蛋去壳后,加入到步骤1得到的药汁中,加热到100℃,即得到治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物。
所述步骤1和步骤2中的药物均由以下成分组成:桦树茸100~200重量份、灰蔸巴200~300重量份、红景天100~200重量份、阴阳子100~200重量份、何首乌100~200重量份、绿萝花50~100重量份、灵芝100~200重量份、金丝红雪茶50~100重量份、天麻子100~200重量份、茴心草100~200重量份、白雪茶100~200重量份、手掌参50~100重量份、昆仑雪菊50~100重量份、龙胆花100~200重量份、杜仲50~100重量份、亚麻籽100~200重量份、野生无柄灵芝50~100重量份、野生黑枸杞50~100g。
本发明的有益效果在于:1.该药物能有效治疗前列腺炎、糖尿病、肾痛肾虚,还对脂肪肝及肝炎患者的治疗具有良好效果,保肝护肝,护肾保肾;2.本发明的药物利用是农副产品禽蛋,是民间一种绿色保健食物补品,人人可吃,人人爱吃,患者吃饭时可以当蔬菜用,也可以随时当零食吃;3.本发明的药物是绿色保健的产品,有治病、保健、通经活血、抗癌性作用,对治疗腰酸背痛有良好效果。4.对经济生活条件困难家庭减轻负担,是国家十三五计划新思路、新发展、新任务、新目标的体现。本专利发明目标是有益为人类身体健康,为世界人民做出更大的贡献!
采用本发明所述的配方对禽蛋进行腌制时,药汁中的有效成分同盐分一起,通过蛋壳、蛋膜、蛋黄膜渗入蛋内,同时,蛋内的水分也不断渗出。药蛋腌制成熟时,蛋液内所含药物成分、食盐成分,与药汁中的药物浓度、食盐浓度基本相近。由于药物和盐分的渗入还有水分的渗出,改变了蛋原来的性状和风味,而蛋内所发生的一系列物理、化学反应,也使得食用药蛋具有了比单纯食用药汁更有效的治疗效果。因此,在原来的配方的基础上,发明人通过腌制咸蛋,以咸蛋为载体,使得配方中的药效能够淋漓尽致地通过咸蛋被人体吸收,治疗效果自然相当可观。
咸蛋本身对人体有很大的好处,据历史记载从明朝初年至今拥有500多年的历史,以前未发现用中草药与蛋混合腌制可治病,而发明人通过对患糖尿病患者的分析,用药物与盐蛋混合腌制进行食用,实现了对脂肪肝、前列腺炎、肾痛肾炎、糖尿病及高血压等疾病的治疗。
附图说明
图1为患者于2014年11月4日的肝胆脾胰肾输尿管膀胱前列腺彩超灰度图;
图2为患者于2015年2月14日的肝胆脾胰肾输尿管膀胱前列腺彩超灰度图;
图3为患者于2015年3月4日的肝胆脾胰肾输尿管膀胱前列腺彩超灰度图;
图4为患者于2015年3月14日的肝胆脾胰肾输尿管膀胱前列腺彩超灰度图;
图5为患者于2015年5月5日的肝胆脾胰肾输尿管膀胱前列腺彩超灰度图。
具体实施方式
1、桦树茸的功能与作用:用于各种疑难杂症,胃癌、肝癌、肠癌、各种消疾病、心脏病、糖尿病,并有排除肠内毒素、美容、减肥等功效。
2、灰蔸巴的功效与作用:用于益气健脾、滋补肾阴、消除、缓解糖尿病症状;改善胰岛素B细胞性不足,促进体内血糖的自然平衡;平衡阴阳,调和气血,纠正代紊乱,防止糖尿病并发症之功效,主要用于治疗II型糖尿病,被誉为是民间治疗糖尿病的优良偏方,降糖尿病药效果试验显著。3、阴阳子的功效与作用:补肾壮阳、祛风除湿、补肝益肾、强身健体,可治疗阳痿滑精、腰膝痿弱、气血不足、筋骨无力,关节酸痛等疾病。
4、何首乌的功效与作用:治疗肝肾阴亏、发须早白、血虚头晕、腰膝软弱、筋骨酸痛、遗精、崩带、久疟、久痢、慢性肝炎,痈肿、瘰疬、肠风、痔疮、红班狼疮等病症。
5、绿萝花的功效与作用:1、降低血糖、平衡糖分在血液中的含量,2、降低血脂、有效降低血液中的血中胆固醇和甘油三酯的含量,达到血液清淤的效果。3、降低血压、平稳血压有效地预防脑卒中和急性冠心病以及引起严重的肾功能衰竭,有助于预防心脑血管疾病和其它非传染疾病。4、冠心病活血、软化动脉血管、抗菌消炎,有扩张血管与增进冠状动脉流量的作用。
6、野生无柄灵芝的功效与作用:和胃健脾、安神定志、扶正培本,补脑溢血,对癌症、心脏病治疗有良好效果,对胃肠、肝脏、肾脏、白血病、神经衰弱、慢性支气管炎疗效显著。
7、金丝红雪茶的功效与作用:降脂,减肥、防治动脉粥样硬化,明显降低血液中的三酰甘油和对人体有害的低密度脂蛋白和超低密度脂蛋白的含量,提高对人有益的高密度胆固醇(HDL)含量,并能促进胆固醇和脂类化合物从粪便中排除,消除体内垃圾,降低胆固醇和中性脂肪在血液和肝脏中积存,具有抗辐射,抗衰老、达到延缓衰老的目的,有很强的杀灭癌细胞的作用。
8、野生黑枸杞的功效与作用:具有补肾益精、养肝明目、补血安神、生津止渴、润肺止咳、治肝肾阴亏、腰膝酸软、头晕目眩、目昏多泪、虚劳咳嗽等疗效。
9、天麻子的功效与作用:补虚定风、眩晕、眼黑、头风头痛、少气失精、须发早白等。
10、茴心草的功效与作用:安神镇静,治疗心脏病心慌、心悸、神经衰弱等症状。
11、白雪茶的功效与作用:能降血压、血脂、血糖、减肥、醒脑润肺、清热解暑、生津止咳、排除毒素、平肝降火、预防消化肠道癌症、高血压、高血糖、高血脂,是消除体内垃圾的最佳品。
12、手掌参的功效与作用:具有止咳平喘,益肾健脾,理气和血、止痛的功效。主肺虚咳喘,虚劳消瘦,神经衰弱、肾虚腰腿酸软,阳痿,慢性肝炎等症状。
13、红景天的功效与作用:治疗气虚血瘀,胸痺心痛、中风偏瘫、倦怠气喘,抗缺氧、抗疲劳、增强耐力,能迅速提高血红蛋白与氧的结合能力,提高血氧饱和度,降低机体内的耗氧量等。
14昆仑雪菊的功效与作用:具有神奇的降血压、降血脂、调节血糖、清肝明目、益肝补阴、抗肿瘤与抗衰老的功效。
15、龙胆花的功效与作用:用于治疗顽固性偏头痛、高血压、急性结膜炎、红膜睫状体炎、急性黄疸性肝炎、急性胆囊炎、急性肾盂肾炎、急性膀胱炎、尿道炎、外阴炎、腹股沟淋巴腺炎等。
16、杜仲的功效与作用:治疗肾亏虚,眩晕症、腰膝筋骨痿弱、慢性肾脏疾病、慢性盆腔炎疾病。
17、亚麻籽的功效与作用:近年来,以加拿大、澳大利亚、英国和美国为主的西方发达国家,对亚麻籽作为功能食品的研究和奥肯迪亚麻籽开发作了大量的工作,以亚麻籽粉为代表的产品早已面市多年,成为中、老年人的常备保健品。最近,符合疗效性要求的高纯度、标准化木酚素提取物的产品也上市,可以广泛应用于胶囊、压片、谷物早餐和快餐食品的添加剂。还有含有ω‐3脂肪酸、可溶性食物纤维和木酚素的营养功能性超浓乳状液和全乳饮料等多种产品不断出现在市场上。而我国在这方面至今基本是空白。
亚麻籽具有抗癌、改善肾虚功能,可治疗类似狼疮之类的自主免疫性疾病,以及溃疡性结肠炎等炎症反应引起的问题。具体具有以下功效:
研究显示亚麻中的木脂素会在肠道里被细菌转变成可以对抗癌症的物质,特别是乳癌。至于用在类风湿性关节炎,研究显示分别以1.8克及1.4克的剂量补充EPA及α‐亚麻脂酸,就有一定的疗效。
狼疮:是一种类似关节炎的严重发炎性疾病,尤其常见于年轻妇女。α‐亚麻油酸可以增强免疫细胞反应,减少体内的发炎现象。它产生作用的机转是改变细胞膜磷脂质(Phospholipids)的组成,显着减少我们生病或受伤时产生的发炎性化合物。《国际肾脏期刊》(KidneyInternational)的一篇研究显示,狼疮病患连续四周每天服用15~45克亚麻籽可以改善肾脏功能,使其血中毒素更稳定地排出体外。由于这种功能,亚麻籽也许可以用来治疗类似狼疮之类的自主免疫性疾病,或其他一般的过敏反应、乾癣,以及溃疡性结肠炎等炎症反应引起的问题。与鱼油合并使用时也很有用,因为omega‐3脂肪酸也对这些问题很有帮助。
增加肠蠕动:根据加拿大多伦多大学(UniversityofToronto)研究人员的报告,亚麻籽补充剂可以改善健康成人的肠蠕动、稍稍降低LDL胆固醇,并提高血中的多元不饱和脂肪酸。10名自愿受试者连续4星期食用烤进面包中的50克亚麻籽油,结果在一周内增加30%的肠糯动。
降低胆固醇:纽泽西州乔丹心脏基金会(JordanHeartFund)的研究小组,对15名胆固醇过高的病患进行评估。自愿受试者每天接受800单位的维生素E、3片含亚麻籽的面包,以及15克的亚麻籽。在试验的3个月申,显着降低血中总胆固醇与LDL胆固醇。不过,HDL胆固醇(好的胆固醇)并没有改变。凝血(thrombin)引起的血小板凝集可能会引起血栓,在实验期中也有所减少。
在澳洲皇家阿德雷德医院(RoyalAdelaideHospital)所进行的研究显示,富含亚麻籽油的饮食可以使血浆中三酸甘油脂、磷脂质(phospholipid)、胆固醇脂(cholersterylester)以及嗜中性球磷脂质(neutrophilphospholipid)中的α‐亚麻脂酸浓度大增。EPA在血浆脂质及嗜中性球磷脂中的浓度增加了2.5倍。
预防心血管疾病:澳洲雪梨大学的研究小组,让11名健康男性每日服用40克亚麻籽油或葵花油23天。血小板的EPA在亚麻籽自愿受试者中增加2倍以上,而葵花油组则维持不变。不过,EPA对花生四烯酸(arachidonicacid)的比例在亚麻籽组有所上升,这个比例值是促血栓素A2(thromboxanA2)生成与血小板凝集潜力的指标(促血栓素会使血管收缩,促进血栓形成,进而可能导致心脏病猝发或中风)。同样的,摄取亚麻籽油的人,其体内由胶原引起的凝集反应也会降低。这些数据是进一步的证据,证明富含α‐亚麻脂酸的油类由於能够防止血小板凝聚在一起,因此,比富含亚麻油酸的油类更能预防心血管疾病。
调节荷尔蒙,改善更年期症状:木脂素还可调节体内荷尔蒙的含量,并舒解更年期带来的一些症状,例如:潮红发热和因阴道干涩引发的真菌感染。亚麻籽油还被用来治可能由荷尔蒙失调引起的经前症群。治疗摄护腺:罗伯恃.吉勒(RobertM.Giller)医师建议,有摄护腺问题的病患可连续数月,每天用1到2汤匙的冷冻压缩亚麻籽油来治疗。
癌症:虽然雌激素对女性的发育和生殖非常重要,但是过多的雌激素可能会导致肿瘤。因为亚麻籽含有温和的植物雌激素,可以对抗体内过多的雌激素,所以一般认为它具有抗癌效果。发表于《癌症发生》的一项研究发现,当罹患乳癌的女性患者连续服用亚麻籽13周,她们的复发性乳房肿瘤明显减少百分之五十。
便秘:便秘不仅不舒服,也会导致肠道阻塞,以及多种症状如疲劳、疼痛和刺激性。《美国临床营养学期刊》的报告指出,连续四周每天服用50克亚麻籽的人,每星期排便次数增加百分之三十。
免疫系统功能不全:亚麻籽最重要的一个成分是α‐亚麻油酸,很多人的饮食中都缺乏这种Omega‐3脂肪酸。必需脂肪酸对身体的复原及类风湿性关节炎、牛皮癣和糖尿病等疾病相关发炎现象的舒缓非常重要。研究显示亚麻籽会促进我们的免疫系统,抑制原发炎性化合物(Pro‐inflammatorycompounds)的制造。
恢复体力、减轻肌肉酸痛:有健身者声称亚麻籽油补充剂可增强耐力,并帮助他们运作之後体能更快恢复。亚麻籽油包含一些天然的抗氧化剂,因此能帮助疲乏的肌肉更快复原。此外,它的抗炎功效还能帮助减轻肌肉酸痛。
18.灵芝的主要作用:一、抗肿瘤作用《中国癌症治疗保护网》吕迪主任认为自身免疫功能的低下或失调,是肿瘤之所以会发生、扩散、转移及较难根治的重要原因。灵芝是最佳的免疫功能调节剂和激活剂,它可显著提高机体的免疫功能,增强患者自身的防癌、抗癌能力。灵芝可以通过促进白细胞介素‐2的等内源性抗癌物质的生成,通过促进单核巨噬细胞的吞噬功能、通过提升人体的造血能力尤其是白细胞的指标水平,以及通过其中某些有效成分对癌细胞的抑制作用,成为抗肿瘤、防癌以及癌症辅助治疗的优选药物。灵芝对人体几乎没有任何毒副作用。这种无毒性的免疫活化剂的优点,恰恰是许多肿瘤化疗药物和其它免疫促进剂都不具有的。二、保肝解毒作用灵芝对多种理化及生物因素引起的肝损伤有保护作用。
19、鸭蛋的功效:清肺火、降阴火适宜肺热咳嗽.咽喉痛,泄痢之人食用。咸蛋黄油有明目养眼的功效,还可治小儿积食,外敷可治烫伤、湿疹。强健身体促进骨骼发育,预防贫血。促进食欲能刺激消化器官。
20.鸡蛋的功效:滋阴润燥;养血发胎;健脑益智。主热病烦闷;燥咳声哑;目赤咽痛;胎动不安;产后口渴;下痢;疟疾;烫伤;皮炎;虚人赢弱。鸡蛋对神经系统和身体发育有很大的有利作用。
21、盐有以下功能:咽喉炎患者,用淡盐水含漱咽部,有消炎止痛的作用;沙眼和眼结膜炎患者,每天清晨用淡盐水洗眼,有明目和治疗作用;用茄根加盐水洗脚,可治疗冻疮;被蜂、蝎、蜈蚣叮咬后,立即用浓盐水洗患处,可止痛消肿去毒;用盐水洗头,可减少头发脱落;用纱布包住炒好的盐,热敷于关节,可治疗因潮湿、风湿等引起的关节炎;体育运动后,用温盐水泡洗脚、腿,可避免次日腿、脚的酸痛和疲劳;洗澡水中放少许盐,可止身痒;每天用淡盐水漱口,可消除口臭;唱歌之前喝点盐开水,可以避免嗓子哑;清晨起来喝一杯盐开水可治大小便不通;误食有毒食物,吃点盐可解毒。盐有以下功能:咽喉炎患者,用淡盐水含漱咽部,有消炎止痛的作用;沙眼和眼结膜炎患者,每天清晨用淡盐水洗眼,有明目和治疗作用;用茄根加盐水洗脚,可治疗冻疮;被蜂、蝎、蜈蚣叮咬后,立即用浓盐水洗患处,可止痛消肿去毒;用盐水洗头,可减少头发脱落;用纱布包住炒好的盐,热敷于关节,可治疗因潮湿、风湿等引起的关节炎;体育运动后,用温盐水泡洗脚、腿,可避免次日腿、脚的酸痛和疲劳;洗澡水中放少许盐,可止身痒;每天用淡盐水漱口,可消除口臭;唱歌之前喝点盐开水,可以避免嗓子哑;清晨起来喝一杯盐开水可治大小便不通;误食有毒食物,吃点盐可解毒。
22.水的营养价值:好水好营养,水作为营养素之一,对人体的作用很大。有人认为水不能与其他营养素相比.没有什么营养价值。其实,对人体来说,水比其他营养素更重要的作用。
本发明一种治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物,是将上述药物对禽蛋进行腌制,药汁中的有效成分同盐分一起,通过蛋壳、蛋膜、蛋黄膜渗入蛋内,同时,蛋内的水分也不断渗出。药蛋腌制成熟时,蛋液内所含药物成分、食盐成分,与药汁中的药物浓度、食盐浓度基本相近。由于药物和盐分的渗入还有水分的渗出,改变了蛋原来的性状和风味,而蛋内所发生的一系列物理、化学反应,也使得食用药蛋具有了比单纯食用药汁更有效的治疗效果。因此,在原来的配方的基础上,发明人通过腌制咸蛋,以咸蛋为载体,使得配方中的药效能够淋漓尽致地通过咸蛋被人体吸收,治疗效果自然相当可观。具体可通过以下两种方法制备得到:
方法一:
将10000~18000g的水加热至100摄氏度,加入1500~3000g食盐,得到食盐溶液;将食盐溶液自然冷却到20~30℃后,加入药物,泡浸两至三天,得到药物浸出液;将180个禽蛋放入药物浸出液中腌制20~40天,腌制后的禽蛋即为治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物;
所述药物由以下成分组成:桦树茸100~200g、灰蔸巴200~300g、红景天100~200g、阴阳子100~200g、何首乌100~200g、绿萝花50~100g、灵芝100~200g、金丝红雪茶50~100g、天麻子100~200g、茴心草100~200g、白雪茶100~200g、手掌参50~100g、昆仑雪菊50~100g、龙胆花100~200g、杜仲50~100g、亚麻籽100~200g、野生无柄灵芝50~100g、野生黑枸杞50~100g。
方法二
(1)将15000g水加热至100℃,加入500~900g食盐,得到食盐溶液;将食盐溶液自然冷却到20~30℃后,加入1500g药物,泡浸2~3个小时;然后在100℃下加热20‐30分钟,得到药汁;
(2)将7000~10000g水加热至100℃,加入2000~3000g食盐,得到食盐溶液;将食盐溶液自然冷却到20~30℃后,加入1000g药物,泡浸两至三天,得到药物浸出液;再将4000~6500g的禽蛋放入药物中腌制20~40天;
(3)将步骤2腌制后的禽蛋去壳后,加入到步骤1得到的药汁中,加热到100℃,即得到治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物;
所述步骤1和步骤2中的药物均由以下成分组成:桦树茸100~200重量份、灰蔸巴200~300重量份、红景天100~200重量份、阴阳子100~200重量份、何首乌100~200重量份、绿萝花50~100重量份、灵芝100~200重量份、金丝红雪茶50~100重量份、天麻子100~200重量份、茴心草100~200重量份、白雪茶100~200重量份、手掌参50~100重量份、昆仑雪菊50~100重量份、龙胆花100~200重量份、杜仲50~100重量份、亚麻籽100~200重量份、野生无柄灵芝50~100重量份、野生黑枸杞50~100g。
下面结合实施例对本发明作进一步说明。
实施例1:糖尿病患者治疗。
用本发明方法一对鸡蛋进行腌制,并以此治疗某糖尿病患者。治疗期间,患者不吃甜的食品,也不喝酒,其它食物照旧。将腌制后的鸡蛋煮熟,每天两次,每次吃1~2个。
经21名II型糖尿病患者试用,初期空腹血糖在10-13之间,在饮用本实施例药物组合物的药液的前三天,空腹血糖上升到17-20,餐后血糖同样升高,随后逐步降低,在使用7~15天血糖会降到安全范围内,然后停止一至二天时间,等血糖恢复正常5~6之间,就不能空腹使用,中午吃饭时吃一个,晚餐吃饭时吃一个,在饮用本实施例药物组合物的药物3个月内,空腹血糖稳定在5-6之间。成功治愈19名。
实施例2:脂肪肝、前列腺炎患者治疗。
用本发明方法二对鸭蛋进行腌制,并以此治疗某脂肪肝、前列腺炎患者,治疗期间,患者不喝酒,其它食物照旧。每天两次,每次喝80~120g的药物。
图1某脂肪肝、前列腺炎患者于2014年11月4日在中南大学湘雅医院的彩超肝胆脾胰肾输尿管膀胱前列腺,图中可知,肝脏内光点细密,分布欠均匀,肝内胆管未见明显扩张,内未见结石,于右肝后叶可见一41×24mm低回声区,边界欠清,内光点粗,分布不均匀,肝内可见多个五回声结节,较大者18×17mm,位于左肝内叶,另于左肝外叶可见一20×16mm低回声结节;此外,双肾内可见多个强光团伴声影,双肾较大者直径均约7mm,右肾下部可见一41×35mm无回声结节。诊断结果为:脂肪肝、肝多发囊肿、前列腺多发钙化灶。
按照上述使用方法对该患者进行治疗,于2015年2月14日再次做检测,如图2所示,肝脏内光点细密,分布均匀;此外,前列腺大小、形态正常,表面光滑,内部回声中等,未见明显结节声像。前列腺炎得到成功治疗。
图3为3月4日的彩超结果,图中可以看出,肝脏大小正常,形态规则,表面光滑,实质回声稍强,光点细,分布均匀,肝内胆管未见明显扩展,内未见结石。肝内可见多个左肝内叶,另于左肝外叶探及一23×12mm的强弱不等回声结节,形态规则,边界清,内光点粗,分布欠均匀。诊断结果为:肝多发囊肿。因此,脂肪肝治疗成功。
从此,患者停药。
如图4和5所示,根据2015年3月14日和2015年5月5日的检查结果可知,停药后,患者的脂肪肝和前列腺炎并没有复发。
按照上述方法对19名前列腺炎患者进行治疗,在饮用本实施例药物组合物的药液三个月之后,17名患者的前列腺炎症状消失。
实施例3:肾痛、高血压患者治疗。
用本发明方法一对鸭蛋进行腌制,并以此治疗某肾痛患者,治疗期间,患者不吃甜的食品,也不喝酒,其它食物照旧。将腌制后的鸭蛋煮熟,每天两次,每次吃1~2个。
用本发明的药物治疗某肾痛患者,吃药后的第一天的肾痛有所缓解,第三天,完全没有痛感;食用二个月后停药,半年内肾痛没有复发。
按照上述方法对15名肾痛患者进行治疗,治疗两~三个月之后,12名患者不再有肾痛的症状。
按照上述方法对23名高压160~179,低压100~109的高血压患者试用,治疗一个月之后,血压即稳定在高压130~140,低压80~95范围内。继续用药两个月,在停药后一个月时间内,20名患者没有出现血压升高的现象。
Claims (2)
1.一种治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物,其特征在于,所述药物通过以下方法制备得到:
将10000‐18000g的水加热至100摄氏度,加入1500~3000g食盐,得到食盐溶液;将食盐溶液自然冷却到20~30℃后,加入药物,泡浸两至三天,得到药物浸出液;将180个的禽蛋放入药物浸出液中腌制20~40天,腌制后的禽蛋即为治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物;所述禽蛋为鸡蛋或鸭蛋;
所述药物由以下成分组成:桦树茸100~200g、灰蔸巴200~300g、红景天100~200g、阴阳子100~200g、何首乌100~200g、绿萝花50~100g、灵芝100~200g、金丝红雪茶50~100g、天麻子100~200g、茴心草100~200g、白雪茶100~200g、手掌参50~100g、昆仑雪菊50~100g、龙胆花100~200g、杜仲50~100g、亚麻籽100~200g、野生无柄灵芝50~100g、野生黑枸杞50~100g。
2.一种治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物,其特征在于,所述药物通过以下步骤制备得到:
(1)将15000g水加热至100℃,加入500~900g食盐,得到食盐溶液;将食盐溶液自然冷却到20~30℃后,加入1500g药物,泡浸2~3个小时;然后在100℃下加热20‐30分钟,得到药汁;
(2)将7000~10000g水加热至100℃,加入2000~3000g食盐,得到食盐溶液;将食盐溶液自然冷却到20~30℃后,加入1000g药物,泡浸两至三天,得到药物浸出液;再将4000~6500g的禽蛋放入药物中腌制20~40天;所述禽蛋为鸡蛋或鸭蛋;
(3)将步骤2腌制后的禽蛋去壳后,加入到步骤1得到的药汁中,加热到100℃,即得到治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物;
所述步骤1和步骤2中的药物均由以下成分组成:桦树茸100~200重量份、灰蔸巴200~300重量份、红景天100~200重量份、阴阳子100~200重量份、何首乌100~200重量份、绿萝花50~100重量份、灵芝100~200重量份、金丝红雪茶50~100重量份、天麻子100~200重量份、茴心草100~200重量份、白雪茶100~200重量份、手掌参50~100重量份、昆仑雪菊50~100重量份、龙胆花100~200重量份、杜仲50~100重量份、亚麻籽100~200重量份、野生无柄灵芝50~100重量份、野生黑枸杞50~100g。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510957777.1A CN105412623A (zh) | 2015-12-18 | 2015-12-18 | 治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510957777.1A CN105412623A (zh) | 2015-12-18 | 2015-12-18 | 治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105412623A true CN105412623A (zh) | 2016-03-23 |
Family
ID=55491466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510957777.1A Pending CN105412623A (zh) | 2015-12-18 | 2015-12-18 | 治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105412623A (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106075101A (zh) * | 2016-07-13 | 2016-11-09 | 卢祥平 | 一种治疗脂肪肝、前列腺炎、糖尿病、肺炎、偏头痛药物 |
CN106138767A (zh) * | 2016-02-29 | 2016-11-23 | 卢昕冉 | 一种治疗脂肪肝、前列腺炎、糖尿病、肺病、胃病的药物 |
CN106177514A (zh) * | 2016-05-05 | 2016-12-07 | 卢祥平 | 一种治疗脂肪肝、前列腺炎、糖尿病、高血压、肺炎、胃肠炎的药物 |
CN106214983A (zh) * | 2016-08-21 | 2016-12-14 | 卢祥平 | 一种治疗脂肪肝、前列腺炎、糖尿病、高血压、肺炎、偏头痛的药物 |
CN107375717A (zh) * | 2016-05-16 | 2017-11-24 | 卢祥平 | 一种治疗脂肪肝、前列腺炎、糖尿病、高血压、咳嗽、胃肠炎的药物 |
CN107397890A (zh) * | 2016-05-18 | 2017-11-28 | 卢昕冉 | 一种治疗脂肪肝、前列腺炎、糖尿病、高血压、胆固醇的药物 |
CN107432915A (zh) * | 2016-05-25 | 2017-12-05 | 卢祥平 | 一种治疗脂肪肝、前列腺炎、糖尿病、高血压、肺炎、胃肠炎的药物 |
CN107432916A (zh) * | 2016-05-25 | 2017-12-05 | 卢祥平 | 一种治疗脂肪肝、前列腺炎、糖尿病、高血压、肝炎、胆固醇的药物 |
CN107467542A (zh) * | 2017-08-10 | 2017-12-15 | 广州回味源蛋类食品有限公司 | 一种具有降脂降醇功效的酸蛋的腌制方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101085068A (zh) * | 2007-06-26 | 2007-12-12 | 张丰强 | 一种治疗2型糖尿病的盛糖平胶囊及其制作方法 |
CN101327230A (zh) * | 2007-06-22 | 2008-12-24 | 付茂康 | 治疗糖尿病的口服药 |
-
2015
- 2015-12-18 CN CN201510957777.1A patent/CN105412623A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101327230A (zh) * | 2007-06-22 | 2008-12-24 | 付茂康 | 治疗糖尿病的口服药 |
CN101085068A (zh) * | 2007-06-26 | 2007-12-12 | 张丰强 | 一种治疗2型糖尿病的盛糖平胶囊及其制作方法 |
Non-Patent Citations (1)
Title |
---|
付惠等: "云南两种地衣茶:白雪茶(Thamnolia spp.)和红雪茶(Lethariella spp.)的营养成分分析", 《天然产物研究与开发》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106138767A (zh) * | 2016-02-29 | 2016-11-23 | 卢昕冉 | 一种治疗脂肪肝、前列腺炎、糖尿病、肺病、胃病的药物 |
CN106177514A (zh) * | 2016-05-05 | 2016-12-07 | 卢祥平 | 一种治疗脂肪肝、前列腺炎、糖尿病、高血压、肺炎、胃肠炎的药物 |
CN107375717A (zh) * | 2016-05-16 | 2017-11-24 | 卢祥平 | 一种治疗脂肪肝、前列腺炎、糖尿病、高血压、咳嗽、胃肠炎的药物 |
CN107397890A (zh) * | 2016-05-18 | 2017-11-28 | 卢昕冉 | 一种治疗脂肪肝、前列腺炎、糖尿病、高血压、胆固醇的药物 |
CN107432915A (zh) * | 2016-05-25 | 2017-12-05 | 卢祥平 | 一种治疗脂肪肝、前列腺炎、糖尿病、高血压、肺炎、胃肠炎的药物 |
CN107432916A (zh) * | 2016-05-25 | 2017-12-05 | 卢祥平 | 一种治疗脂肪肝、前列腺炎、糖尿病、高血压、肝炎、胆固醇的药物 |
CN106075101A (zh) * | 2016-07-13 | 2016-11-09 | 卢祥平 | 一种治疗脂肪肝、前列腺炎、糖尿病、肺炎、偏头痛药物 |
CN106214983A (zh) * | 2016-08-21 | 2016-12-14 | 卢祥平 | 一种治疗脂肪肝、前列腺炎、糖尿病、高血压、肺炎、偏头痛的药物 |
CN107467542A (zh) * | 2017-08-10 | 2017-12-15 | 广州回味源蛋类食品有限公司 | 一种具有降脂降醇功效的酸蛋的腌制方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105412623A (zh) | 治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物 | |
CN104825816A (zh) | 一种治疗脂肪肝、前列腺炎、糖尿病、肾痛肾虚的药物 | |
CN103719492B (zh) | 一种绞股蓝护肝养肝保健茶及其制备方法 | |
CN105233010A (zh) | 一种补肾壮阳酒及其制备方法 | |
CN105727081A (zh) | 一种用于治疗痛风的保健品组合物 | |
CN101579120A (zh) | 一种具有减肥功能的营养食品及其制备方法 | |
CN105232907A (zh) | 一种补肾壮阳饮料及其制备方法 | |
CN102772781A (zh) | 一种治疗慢性结肠炎的中药制剂及其制备方法 | |
CN104998252B (zh) | 一种补铁补血口服液及其制备方法 | |
CN103610077A (zh) | 一种海参胶囊 | |
CN107432915A (zh) | 一种治疗脂肪肝、前列腺炎、糖尿病、高血压、肺炎、胃肠炎的药物 | |
CN102599595B (zh) | 具有降血脂作用的保健饮品、中药及制备方法 | |
CN107375717A (zh) | 一种治疗脂肪肝、前列腺炎、糖尿病、高血压、咳嗽、胃肠炎的药物 | |
CN104187246A (zh) | 一种功能性红糖及其制备方法 | |
CN104432386B (zh) | 一种防治腰膝酸软、筋骨无力的桑寄生口服液及其制备方法 | |
CN103525640B (zh) | 一种活力壮阳酒 | |
CN103181557A (zh) | 具有减肥功能的营养食品及其制备方法 | |
CN103656150B (zh) | 一种养生保健口服液及其制备方法 | |
CN106177514A (zh) | 一种治疗脂肪肝、前列腺炎、糖尿病、高血压、肺炎、胃肠炎的药物 | |
CN112076305A (zh) | 一种治疗人体代谢症候群及杀菌消炎的中药制内服外用原液合剂 | |
CN107397890A (zh) | 一种治疗脂肪肝、前列腺炎、糖尿病、高血压、胆固醇的药物 | |
CN106728565A (zh) | 一种全蝎药醋液及其制备方法 | |
CN106138310A (zh) | 用微量元素保健品和中药治疗ⅱ型糖尿病的方法 | |
CN103933368B (zh) | 用于治疗产后便秘的药物组合物及其制备方法 | |
CN110694014A (zh) | 一种预防和治疗血栓的组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160323 |